...
机译:Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data
Medical Oncology Department,IRCSS San Raffaele Scientific Institute;
Medical Oncology,University Hospital of Pisa;
Medical Oncology 3,Veneto Institute of Oncology IOV – IRCCSMedical Oncology Department,Fondazione IRCCS Istituto Nazionale dei TumoriClinical Oncology Unit,Careggi University HospitalMedical Oncology and Hematology Unit, Humanitas Cancer Center,IRCCS Humanitas Research HospitalDivision of Medical Oncology,Fondazione Policlinico Universitario Campus Bio‐MedicoUnit of Medical Oncology and Biomolecular Therapy,Policlinico RiunitiMedical Oncology,University and University HospitalDepartment of Oncology and Palliative Care,Cardinale G Panico, Tricase City HospitalMedical Oncology Unit 1,Ospedale Policlinico San Martino – IRCCSDepartment of Medical Oncology,IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “DinoMedical Oncology Unit, Ospedale del MareMedical Oncology Unit, Department of Precision Medicine,Università Degli Studi Della CampaniaMedical Oncology Unit,University Hospital of ParmaDepartment of Oncology,San Bortolo General Hospital, Azienda ULSS8 BericaMedical Oncology Unit, Department of Oncology and Hematology,Belcolle HospitalMedical Oncology Unit, Department of Systems Medicine,Tor Vergata University HospitalMedical Oncology 1,Veneto Institute of Oncology IOV – IRCCSOncology Unit,San Martino HospitalHepatobiliary Surgery Division,Vita‐Salute San Raffaele University, IRCCS San Raffaele Scientific;